PHASE IB/II STUDY OF SECOND LINE THERAPY WITH PANITUMUMAB, IRINOTECAN AND EVEROLIMUS (PIE) IN KRAS WILD TYPE METASTATIC COLORECTAL CANCER
Townsend, Amanda, Tebbutt, Niall C, Karapetis, Christos S, Cooper, Pamela, Singhal, Nimit, Yeend, Sue J, Pirc, Louise, Joshi, Rohit, Hardingham, Jennifer Elizabeth, Price, TimothyLanguage:
english
Journal:
Clinical Cancer Research
DOI:
10.1158/1078-0432.CCR-17-3590
Date:
May, 2018
File:
PDF, 1.71 MB
english, 2018